APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Spasmolytic Injections

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Spasmolytic Injections Industry Growth and Trends Forecast to 2032

Report ID 174037140129 December 2025111 pages

Choose your research edition.

Industry ResearchSpasmolytic Injections Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Spasmolytic Injections Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Spasmolytic Injections Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Spasmolytic Injections Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Spasmolytic Injections Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

According to APO Research, the global Spasmolytic Injections market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Spasmolytic Injections is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Spasmolytic Injections is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Spasmolytic Injections is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Spasmolytic Injections market include AdvaCare Pharma, Allergan, Baxter International, Boehringer Ingelheim, Chengdu Better Pharmaceutical, CNS Therapeutics, Huarun Shuanghe, Ipsen and Medytox, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Spasmolytic Injections market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Spasmolytic Injections market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Spasmolytic Injections market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Spasmolytic Injections.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Spasmolytic Injections market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Spasmolytic Injections Market by Company

AdvaCare Pharma

Allergan

Baxter International

Boehringer Ingelheim

Chengdu Better Pharmaceutical

CNS Therapeutics

Huarun Shuanghe

Ipsen

Medytox

Nanjing Hangsheng Pharmaceutical

Sun Pharmaceutical Industries

Wanbangde Pharmaceutical Group

Wuhan Renfu Pharmaceutical

Zydus Cadila

Lilly

Mylan

Sanofi

Teva Pharmaceuticals

Spasmolytic Injections Segment by Type

Papaverines

Anticholinergics

Calcium Channel Blockers

Others

Spasmolytic Injections Segment by Application

Hospital

Clinic

Spasmolytic Injections Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Spasmolytic Injections market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Spasmolytic Injections and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Spasmolytic Injections.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Spasmolytic Injections companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Spasmolytic Injections Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Spasmolytic Injections Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Spasmolytic Injections Market Share by Region (2021-2026) Table 4. Global Spasmolytic Injections Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Spasmolytic Injections Market Share by Region (2027-2032) Table 6. Global Spasmolytic Injections Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Spasmolytic Injections Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Spasmolytic Injections Market Size Share by Type (2021-2026) Table 9. Global Spasmolytic Injections Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Spasmolytic Injections Market Size Share Forecasted by Type (2027-2032) Table 11. North America Spasmolytic Injections Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Spasmolytic Injections Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Spasmolytic Injections Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Spasmolytic Injections Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Spasmolytic Injections Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Spasmolytic Injections Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Spasmolytic Injections Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Spasmolytic Injections Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Spasmolytic Injections Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Spasmolytic Injections Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Spasmolytic Injections Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Spasmolytic Injections Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Spasmolytic Injections Market Size Share by Application (2021-2026) Table 24. Global Spasmolytic Injections Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Spasmolytic Injections Market Size Share Forecasted by Application (2027-2032) Table 26. North America Spasmolytic Injections Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Spasmolytic Injections Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Spasmolytic Injections Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Spasmolytic Injections Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Spasmolytic Injections Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Spasmolytic Injections Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Spasmolytic Injections Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Spasmolytic Injections Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Spasmolytic Injections Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Spasmolytic Injections Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Spasmolytic Injections Industry Trends Table 37. Spasmolytic Injections Industry Drivers Table 38. Spasmolytic Injections Industry Opportunities and Challenges Table 39. Spasmolytic Injections Industry Restraints Table 40. Global Spasmolytic Injections Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Spasmolytic Injections Revenue Market Share by Company (2021-2026) Table 42. Global Spasmolytic Injections Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Spasmolytic Injections Key Company Headquarters & Area Served Table 44. Global Spasmolytic Injections Company, Product Type & Application Table 45. Global Spasmolytic Injections Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Spasmolytic Injections by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. AdvaCare Pharma Company Information Table 49. AdvaCare Pharma Business Overview Table 50. AdvaCare Pharma Spasmolytic Injections Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. AdvaCare Pharma Spasmolytic Injections Product Portfolio Table 52. AdvaCare Pharma Recent Development Table 53. Allergan Company Information Table 54. Allergan Business Overview Table 55. Allergan Spasmolytic Injections Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Allergan Spasmolytic Injections Product Portfolio Table 57. Allergan Recent Development Table 58. Baxter International Company Information Table 59. Baxter International Business Overview Table 60. Baxter International Spasmolytic Injections Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Baxter International Spasmolytic Injections Product Portfolio Table 62. Baxter International Recent Development Table 63. Boehringer Ingelheim Company Information Table 64. Boehringer Ingelheim Business Overview Table 65. Boehringer Ingelheim Spasmolytic Injections Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Boehringer Ingelheim Spasmolytic Injections Product Portfolio Table 67. Boehringer Ingelheim Recent Development Table 68. Chengdu Better Pharmaceutical Company Information Table 69. Chengdu Better Pharmaceutical Business Overview Table 70. Chengdu Better Pharmaceutical Spasmolytic Injections Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Chengdu Better Pharmaceutical Spasmolytic Injections Product Portfolio Table 72. Chengdu Better Pharmaceutical Recent Development Table 73. CNS Therapeutics Company Information Table 74. CNS Therapeutics Business Overview Table 75. CNS Therapeutics Spasmolytic Injections Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. CNS Therapeutics Spasmolytic Injections Product Portfolio Table 77. CNS Therapeutics Recent Development Table 78. Huarun Shuanghe Company Information Table 79. Huarun Shuanghe Business Overview Table 80. Huarun Shuanghe Spasmolytic Injections Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Huarun Shuanghe Spasmolytic Injections Product Portfolio Table 82. Huarun Shuanghe Recent Development Table 83. Ipsen Company Information Table 84. Ipsen Business Overview Table 85. Ipsen Spasmolytic Injections Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Ipsen Spasmolytic Injections Product Portfolio Table 87. Ipsen Recent Development Table 88. Medytox Company Information Table 89. Medytox Business Overview Table 90. Medytox Spasmolytic Injections Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Medytox Spasmolytic Injections Product Portfolio Table 92. Medytox Recent Development Table 93. Nanjing Hangsheng Pharmaceutical Company Information Table 94. Nanjing Hangsheng Pharmaceutical Business Overview Table 95. Nanjing Hangsheng Pharmaceutical Spasmolytic Injections Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Nanjing Hangsheng Pharmaceutical Spasmolytic Injections Product Portfolio Table 97. Nanjing Hangsheng Pharmaceutical Recent Development Table 98. Sun Pharmaceutical Industries Company Information Table 99. Sun Pharmaceutical Industries Business Overview Table 100. Sun Pharmaceutical Industries Spasmolytic Injections Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Sun Pharmaceutical Industries Spasmolytic Injections Product Portfolio Table 102. Sun Pharmaceutical Industries Recent Development Table 103. Wanbangde Pharmaceutical Group Company Information Table 104. Wanbangde Pharmaceutical Group Business Overview Table 105. Wanbangde Pharmaceutical Group Spasmolytic Injections Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Wanbangde Pharmaceutical Group Spasmolytic Injections Product Portfolio Table 107. Wanbangde Pharmaceutical Group Recent Development Table 108. Wuhan Renfu Pharmaceutical Company Information Table 109. Wuhan Renfu Pharmaceutical Business Overview Table 110. Wuhan Renfu Pharmaceutical Spasmolytic Injections Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Wuhan Renfu Pharmaceutical Spasmolytic Injections Product Portfolio Table 112. Wuhan Renfu Pharmaceutical Recent Development Table 113. Zydus Cadila Company Information Table 114. Zydus Cadila Business Overview Table 115. Zydus Cadila Spasmolytic Injections Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Zydus Cadila Spasmolytic Injections Product Portfolio Table 117. Zydus Cadila Recent Development Table 118. Lilly Company Information Table 119. Lilly Business Overview Table 120. Lilly Spasmolytic Injections Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Lilly Spasmolytic Injections Product Portfolio Table 122. Lilly Recent Development Table 123. Mylan Company Information Table 124. Mylan Business Overview Table 125. Mylan Spasmolytic Injections Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Mylan Spasmolytic Injections Product Portfolio Table 127. Mylan Recent Development Table 128. Sanofi Company Information Table 129. Sanofi Business Overview Table 130. Sanofi Spasmolytic Injections Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Sanofi Spasmolytic Injections Product Portfolio Table 132. Sanofi Recent Development Table 133. Teva Pharmaceuticals Company Information Table 134. Teva Pharmaceuticals Business Overview Table 135. Teva Pharmaceuticals Spasmolytic Injections Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Teva Pharmaceuticals Spasmolytic Injections Product Portfolio Table 137. Teva Pharmaceuticals Recent Development Table 138. North America Spasmolytic Injections Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. North America Spasmolytic Injections Market Size by Country (2021-2026) & (US$ Million) Table 140. North America Spasmolytic Injections Market Share by Country (2021-2026) Table 141. North America Spasmolytic Injections Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. North America Spasmolytic Injections Market Share Forecast by Country (2027-2032) Table 143. Europe Spasmolytic Injections Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Europe Spasmolytic Injections Market Size by Country (2021-2026) & (US$ Million) Table 145. Europe Spasmolytic Injections Market Share by Country (2021-2026) Table 146. Europe Spasmolytic Injections Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Europe Spasmolytic Injections Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific Spasmolytic Injections Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific Spasmolytic Injections Market Size by Country (2021-2026) & (US$ Million) Table 150. Asia-Pacific Spasmolytic Injections Market Share by Country (2021-2026) Table 151. Asia-Pacific Spasmolytic Injections Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Asia-Pacific Spasmolytic Injections Market Share Forecast by Country (2027-2032) Table 153. Latin America Spasmolytic Injections Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Latin America Spasmolytic Injections Market Size by Country (2021-2026) & (US$ Million) Table 155. Latin America Spasmolytic Injections Market Share by Country (2021-2026) Table 156. Latin America Spasmolytic Injections Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Latin America Spasmolytic Injections Market Share Forecast by Country (2027-2032) Table 158. Middle East & Africa Spasmolytic Injections Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Middle East & Africa Spasmolytic Injections Market Size by Country (2021-2026) & (US$ Million) Table 160. Middle East & Africa Spasmolytic Injections Market Share by Country (2021-2026) Table 161. Middle East & Africa Spasmolytic Injections Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Middle East & Africa Spasmolytic Injections Market Share Forecast by Country (2027-2032) Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Spasmolytic Injections Product Image Figure 3. Global Spasmolytic Injections Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Spasmolytic Injections Market Size (2021-2032) & (US$ Million) Figure 5. Global Spasmolytic Injections Market Share by Region: 2025 VS 2032 Figure 6. Global Spasmolytic Injections Market Share by Region (2021-2032) Figure 7. North America Spasmolytic Injections Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Spasmolytic Injections Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Spasmolytic Injections Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Spasmolytic Injections Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Spasmolytic Injections Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Papaverines Image Figure 13. Global Papaverines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Anticholinergics Image Figure 15. Global Anticholinergics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Calcium Channel Blockers Image Figure 17. Global Calcium Channel Blockers Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Others Image Figure 19. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Spasmolytic Injections Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Spasmolytic Injections Market Share by Type 2025 VS 2032 Figure 22. North America Spasmolytic Injections Market Size Share by Type (2021-2032) Figure 23. Europe Spasmolytic Injections Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Spasmolytic Injections Market Size Share by Type (2021-2032) Figure 25. Latin America Spasmolytic Injections Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Spasmolytic Injections Market Size Share by Type (2021-2032) Figure 27. Hospital Image Figure 28. Global Hospital Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Clinic Image Figure 30. Global Clinic Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Global Spasmolytic Injections Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Spasmolytic Injections Market Share by Application 2025 VS 2032 Figure 33. North America Spasmolytic Injections Market Size Share by Application (2021-2032) Figure 34. Europe Spasmolytic Injections Market Size Share by Application (2021-2032) Figure 35. Asia-Pacific Spasmolytic Injections Market Size Share by Application (2021-2032) Figure 36. Latin America Spasmolytic Injections Market Size Share by Application (2021-2032) Figure 37. Middle East and Africa Spasmolytic Injections Market Size Share by Application (2021-2032) Figure 38. Global Top 5 and 10 Spasmolytic Injections Players Market Share by Revenue in 2025 Figure 39. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 40. North America Spasmolytic Injections Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 41. North America Spasmolytic Injections Market Share by Country: 2021 VS 2025 VS 2032 Figure 42. North America Spasmolytic Injections Market Share by Country (2021-2032) Figure 43. Europe Spasmolytic Injections Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. Europe Spasmolytic Injections Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Spasmolytic Injections Market Share by Country (2021-2032) Figure 46. Asia-Pacific Spasmolytic Injections Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. Asia-Pacific Spasmolytic Injections Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. Asia-Pacific Spasmolytic Injections Market Share by Country (2021-2032) Figure 49. Latin America Spasmolytic Injections Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Latin America Spasmolytic Injections Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Spasmolytic Injections Market Share by Country (2021-2032) Figure 52. Middle East & Africa Spasmolytic Injections Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Middle East & Africa Spasmolytic Injections Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Middle East & Africa Spasmolytic Injections Market Share by Country (2021-2032) Figure 55. Years Considered Figure 56. Research Process Figure 57. Key Executives Interviewed

Scope & coverage.

Types
  • Papaverines
  • Anticholinergics
  • Calcium Channel Blockers
  • Others
Applications
  • Hospital
  • Clinic
Companies covered
  • AdvaCare Pharma
  • Allergan
  • Baxter International
  • Boehringer Ingelheim
  • Chengdu Better Pharmaceutical
  • CNS Therapeutics
  • Huarun Shuanghe
  • Ipsen
  • Medytox
  • Nanjing Hangsheng Pharmaceutical
  • Sun Pharmaceutical Industries
  • Wanbangde Pharmaceutical Group
  • Wuhan Renfu Pharmaceutical
  • Zydus Cadila
  • Lilly
  • Mylan
  • Sanofi
  • Teva Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Spasmolytic Injections Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Spasmolytic Injections Market Size by Region (2021-2032)
  5. 1.4.1 Global Spasmolytic Injections Market Size by Region (2021-2026)
  6. 1.4.2 Global Spasmolytic Injections Market Size by Region (2027-2032)
  7. 1.5 Key Regions Spasmolytic Injections Market Size (2021-2032)
  8. 1.5.1 North America Spasmolytic Injections Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Spasmolytic Injections Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Spasmolytic Injections Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Spasmolytic Injections Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Spasmolytic Injections Market Size Growth Rate (2021-2032)
2 Spasmolytic Injections Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Papaverines
  3. 2.1.2 Anticholinergics
  4. 2.1.3 Calcium Channel Blockers
  5. 2.1.4 Others
  6. 2.2 Global Spasmolytic Injections Market Size by Type
  7. 2.2.1 Global Spasmolytic Injections Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Spasmolytic Injections Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Spasmolytic Injections Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Spasmolytic Injections Market Size by Regions
  11. 2.3.1 North America Spasmolytic Injections Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Spasmolytic Injections Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Spasmolytic Injections Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Spasmolytic Injections Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Spasmolytic Injections Market Size Breakdown by Type (2021-2026)
3 Spasmolytic Injections Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital
  3. 3.1.2 Clinic
  4. 3.2 Global Spasmolytic Injections Market Size by Application
  5. 3.2.1 Global Spasmolytic Injections Market Size Overview by Application (2021-2032)
  6. 3.2.2 Global Spasmolytic Injections Historic Market Size Review by Application (2021-2026)
  7. 3.2.3 Global Spasmolytic Injections Market Size Forecasted by Application (2027-2032)
  8. 3.3 Global Spasmolytic Injections Market Size by Regions
  9. 3.3.1 North America Spasmolytic Injections Market Size Breakdown by Application (2021-2026)
  10. 3.3.2 Europe Spasmolytic Injections Market Size Breakdown by Application (2021-2026)
  11. 3.3.3 Asia-Pacific Spasmolytic Injections Market Size Breakdown by Application (2021-2026)
  12. 3.3.4 South America Spasmolytic Injections Market Size Breakdown by Application (2021-2026)
  13. 3.3.5 Middle East and Africa Spasmolytic Injections Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Spasmolytic Injections Industry Trends
  2. 4.2 Spasmolytic Injections Industry Drivers
  3. 4.3 Spasmolytic Injections Industry Opportunities and Challenges
  4. 4.4 Spasmolytic Injections Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Spasmolytic Injections Revenue (2021-2026)
  2. 5.2 Global Spasmolytic Injections Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Spasmolytic Injections Key Company Headquarters & Area Served
  4. 5.4 Global Spasmolytic Injections Company, Product Type & Application
  5. 5.5 Global Spasmolytic Injections Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Spasmolytic Injections Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Spasmolytic Injections Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Spasmolytic Injections Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 AdvaCare Pharma
  2. 6.1.1 AdvaCare Pharma Company Information
  3. 6.1.2 AdvaCare Pharma Business Overview
  4. 6.1.3 AdvaCare Pharma Spasmolytic Injections Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 AdvaCare Pharma Spasmolytic Injections Product Portfolio
  6. 6.1.5 AdvaCare Pharma Recent Developments
  7. 6.2 Allergan
  8. 6.2.1 Allergan Company Information
  9. 6.2.2 Allergan Business Overview
  10. 6.2.3 Allergan Spasmolytic Injections Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Allergan Spasmolytic Injections Product Portfolio
  12. 6.2.5 Allergan Recent Developments
  13. 6.3 Baxter International
  14. 6.3.1 Baxter International Company Information
  15. 6.3.2 Baxter International Business Overview
  16. 6.3.3 Baxter International Spasmolytic Injections Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Baxter International Spasmolytic Injections Product Portfolio
  18. 6.3.5 Baxter International Recent Developments
  19. 6.4 Boehringer Ingelheim
  20. 6.4.1 Boehringer Ingelheim Company Information
  21. 6.4.2 Boehringer Ingelheim Business Overview
  22. 6.4.3 Boehringer Ingelheim Spasmolytic Injections Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Boehringer Ingelheim Spasmolytic Injections Product Portfolio
  24. 6.4.5 Boehringer Ingelheim Recent Developments
  25. 6.5 Chengdu Better Pharmaceutical
  26. 6.5.1 Chengdu Better Pharmaceutical Company Information
  27. 6.5.2 Chengdu Better Pharmaceutical Business Overview
  28. 6.5.3 Chengdu Better Pharmaceutical Spasmolytic Injections Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Chengdu Better Pharmaceutical Spasmolytic Injections Product Portfolio
  30. 6.5.5 Chengdu Better Pharmaceutical Recent Developments
  31. 6.6 CNS Therapeutics
  32. 6.6.1 CNS Therapeutics Company Information
  33. 6.6.2 CNS Therapeutics Business Overview
  34. 6.6.3 CNS Therapeutics Spasmolytic Injections Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 CNS Therapeutics Spasmolytic Injections Product Portfolio
  36. 6.6.5 CNS Therapeutics Recent Developments
  37. 6.7 Huarun Shuanghe
  38. 6.7.1 Huarun Shuanghe Company Information
  39. 6.7.2 Huarun Shuanghe Business Overview
  40. 6.7.3 Huarun Shuanghe Spasmolytic Injections Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Huarun Shuanghe Spasmolytic Injections Product Portfolio
  42. 6.7.5 Huarun Shuanghe Recent Developments
  43. 6.8 Ipsen
  44. 6.8.1 Ipsen Company Information
  45. 6.8.2 Ipsen Business Overview
  46. 6.8.3 Ipsen Spasmolytic Injections Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Ipsen Spasmolytic Injections Product Portfolio
  48. 6.8.5 Ipsen Recent Developments
  49. 6.9 Medytox
  50. 6.9.1 Medytox Company Information
  51. 6.9.2 Medytox Business Overview
  52. 6.9.3 Medytox Spasmolytic Injections Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Medytox Spasmolytic Injections Product Portfolio
  54. 6.9.5 Medytox Recent Developments
  55. 6.10 Nanjing Hangsheng Pharmaceutical
  56. 6.10.1 Nanjing Hangsheng Pharmaceutical Company Information
  57. 6.10.2 Nanjing Hangsheng Pharmaceutical Business Overview
  58. 6.10.3 Nanjing Hangsheng Pharmaceutical Spasmolytic Injections Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Nanjing Hangsheng Pharmaceutical Spasmolytic Injections Product Portfolio
  60. 6.10.5 Nanjing Hangsheng Pharmaceutical Recent Developments
  61. 6.11 Sun Pharmaceutical Industries
  62. 6.11.1 Sun Pharmaceutical Industries Company Information
  63. 6.11.2 Sun Pharmaceutical Industries Business Overview
  64. 6.11.3 Sun Pharmaceutical Industries Spasmolytic Injections Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Sun Pharmaceutical Industries Spasmolytic Injections Product Portfolio
  66. 6.11.5 Sun Pharmaceutical Industries Recent Developments
  67. 6.12 Wanbangde Pharmaceutical Group
  68. 6.12.1 Wanbangde Pharmaceutical Group Company Information
  69. 6.12.2 Wanbangde Pharmaceutical Group Business Overview
  70. 6.12.3 Wanbangde Pharmaceutical Group Spasmolytic Injections Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Wanbangde Pharmaceutical Group Spasmolytic Injections Product Portfolio
  72. 6.12.5 Wanbangde Pharmaceutical Group Recent Developments
  73. 6.13 Wuhan Renfu Pharmaceutical
  74. 6.13.1 Wuhan Renfu Pharmaceutical Company Information
  75. 6.13.2 Wuhan Renfu Pharmaceutical Business Overview
  76. 6.13.3 Wuhan Renfu Pharmaceutical Spasmolytic Injections Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Wuhan Renfu Pharmaceutical Spasmolytic Injections Product Portfolio
  78. 6.13.5 Wuhan Renfu Pharmaceutical Recent Developments
  79. 6.14 Zydus Cadila
  80. 6.14.1 Zydus Cadila Company Information
  81. 6.14.2 Zydus Cadila Business Overview
  82. 6.14.3 Zydus Cadila Spasmolytic Injections Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Zydus Cadila Spasmolytic Injections Product Portfolio
  84. 6.14.5 Zydus Cadila Recent Developments
  85. 6.15 Lilly
  86. 6.15.1 Lilly Company Information
  87. 6.15.2 Lilly Business Overview
  88. 6.15.3 Lilly Spasmolytic Injections Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Lilly Spasmolytic Injections Product Portfolio
  90. 6.15.5 Lilly Recent Developments
  91. 6.16 Mylan
  92. 6.16.1 Mylan Company Information
  93. 6.16.2 Mylan Business Overview
  94. 6.16.3 Mylan Spasmolytic Injections Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Mylan Spasmolytic Injections Product Portfolio
  96. 6.16.5 Mylan Recent Developments
  97. 6.17 Sanofi
  98. 6.17.1 Sanofi Company Information
  99. 6.17.2 Sanofi Business Overview
  100. 6.17.3 Sanofi Spasmolytic Injections Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Sanofi Spasmolytic Injections Product Portfolio
  102. 6.17.5 Sanofi Recent Developments
  103. 6.18 Teva Pharmaceuticals
  104. 6.18.1 Teva Pharmaceuticals Company Information
  105. 6.18.2 Teva Pharmaceuticals Business Overview
  106. 6.18.3 Teva Pharmaceuticals Spasmolytic Injections Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Teva Pharmaceuticals Spasmolytic Injections Product Portfolio
  108. 6.18.5 Teva Pharmaceuticals Recent Developments
7 North America
  1. 7.1 North America Spasmolytic Injections Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Spasmolytic Injections Market Size by Country (2021-2026)
  3. 7.3 North America Spasmolytic Injections Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Spasmolytic Injections Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Spasmolytic Injections Market Size by Country (2021-2026)
  3. 8.3 Europe Spasmolytic Injections Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Spasmolytic Injections Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Spasmolytic Injections Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Spasmolytic Injections Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Spasmolytic Injections Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Spasmolytic Injections Market Size by Country (2021-2026)
  3. 10.3 South America Spasmolytic Injections Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Spasmolytic Injections Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Spasmolytic Injections Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Spasmolytic Injections Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst